Figure (Be5259c0 Aab1 4703 853c 453a7e8041c4 01)
Tizanidine Tablet
Product Images NDC 70771-1335
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 70771-1335). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure (Be5259c0 Aab1 4703 853c 453a7e8041c4 02)
Figure (Be5259c0 Aab1 4703 853c 453a7e8041c4 03)
Figure (Be5259c0 Aab1 4703 853c 453a7e8041c4 04)
The text describes the improvement of Ashworth score observed during a study of Tizanidine medication. The study lasted for 7 weeks, and the average dose of Tizanidine was 26.8 mg. The Ashworth score was measured at the End of Titration, End of Maintenance, and Endpoint.*
Figure (Be5259c0 Aab1 4703 853c 453a7e8041c4 05)
NDC 7077113358 is a medication named Tizanidine. It comes in tablet form and contains 2.29 mg of izanidine hydrochiorde, equivalent to 2 mg of tizanidine base. The usual dosage is available in the package insert. It should be stored within the temperature range of 20° to 25°C (68 to 77°F) as per USP Controlled Room Temperature regulation. It should be dispensed in a tight container with a child-resistant closure. The manufacturer is Cadila Healthcare Ltd, located in Matoda, Ahmedabad, India. Users need to keep it out of reach from children.*
Figure (Be5259c0 Aab1 4703 853c 453a7e8041c4 06)
Tizanidine Tablets are prescribed for muscle spasms. The USP tablets contain 4.58 mg of tizanidine hydrochloride, equivalent to 4 mg of tizanidine base. They should be stored at a controlled room temperature of 20°C to 25°C. The medicine must be kept away from children in a tight container that has a child-resistant closure. The usual dosage is specified in the package insert. Tizanidine tablets should not be confused with tizanidine capsules. The medication must be taken exactly as prescribed. The manufacturer of Tizanidine Tablets, USP is Cadila Healthcare Ltd, located in Matoda, Ahmedabad, India.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
